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e under theAbstract Background: Interferon gamma release assays (IGRAs) have been shown
to be highly dynamic tests when used in serial testing for TB infection. However,
there is little information demonstrating a clear association between TB exposure
and IGRA responses over time, particularly in high TB incidence settings.
Objectives: To assess whether QuantiFERON-TB Gold In-Tube (QFT) responses are
associated with occupational TB exposures in a cohort of young health care trainees
in India.
Methods: All medical and nursing students at Mahatma Gandhi Institute of Medi-
cal Sciences were approached. Participants were followed up for 18 months; QFT
was performed 4 times, once every 6 months. Various modeling approaches were
used to define IFN-gamma trajectories and correlations with TB exposure.
Results: Among 270 medical and nursing trainees, high rates of conversions (6.3–
20.9%) and reversions (20.0–26.2%) were found depending on the definitions used.
Stable converters were more likely to have had TB exposure in hospital pre-study.3 Ministry of Health, Saudi Arabia. Published by Elsevier Ltd.
3.03.003
cGill University, Depart-
cs, 1020 Pine Ave. West,
+1 514 398 5422; fax: +1
gill.ca (M. Pai).
CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
106 A. Zwerling et al.Recent occupational exposures were not consistently associated with QFT responses
over time.
Conclusion: IFN-gamma responses and rates of change could not be explained by
occupational exposure investigated. High conversion and subsequent reversion rates
suggest many health care workers (HCWs) would revert in the absence of treatment,
either by clearing the infection naturally or due to fluctuations in the underlying
immunological response and/or poor assay reproducibility. QFT may not be an ideal
diagnostic test for repeated screening of HCWs in a high TB incidence setting.
ª 2013 Ministry of Health, Saudi Arabia. Published by Elsevier Ltd. This is an open
access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/
by-nc-nd/4.0/).1. Introduction
India accounts for one fifth of the global TB
burden [1–3], and as such, Indian health care
workers (HCWs) are consistently at an increased
risk of occupational exposure to TB, development
of latent TB infection (LTBI) and active disease
[4–7].
In 2009, the World Health Organization (WHO)
released guidelines on TB infection control (TBIC)
in resource-limited settings and is now actively
promoting TBIC in high TB burden countries [8].
The emergence of multi-drug resistance (MDR) [9]
and extensively drug-resistant (XDR-TB) [10] strains
has heightened the necessity for TBIC measures,
and reinforces the importance of protecting the
health care work force [10].
Annual screening of HCWs for LTBI is a critical
element in TBIC programs in developed countries
and is now gaining some attention in resource-lim-
ited countries as well [11]. Traditionally, screening
HCWs for LTBI was performed with the tuberculin
skin test (TST), but interferon-gamma release as-
says (IGRAs) are now available as an alternative
[12,13]. IGRAs have logistical advantages which
make them attractive for use in serial testing of
HCWs, and systematic reviews have shown both
tests (TST and IGRAs) estimate similar rates of pos-
itivity in high TB incidence settings such as India
[14].
Screening HCWs for LTBI in high TB incidence
settings poses many challenges, including a high
level of repeated exposures, re-infection, and lim-
ited resources to carry out screening or offer iso-
niazid preventive therapy (IPT) when necessary.
Early serial testing studies suggest IGRA results
may be highly variable over time, resulting in
higher frequencies of conversions and spontaneous
reversions than seen with the conventional TST
[15]; many groups are now exploring alternative
IGRA conversion definitions or the use of a border-
line zone for values close to the cut-off that
might better correlate with true instances of
new infection [16,17]. However, these analyseshave been conducted largely in low TB incidence
settings, and data are still lacking as to the extent
to which IGRA conversions or rates of change are
associated with TB exposure (as a proxy for the
likelihood of TB infection) in a high TB incidence
setting.
1.1. Study objectives
Study objectives were firstly to estimate rates of
QuantiFERON-TB Gold In-Tube (QFT) conversions
and reversions in Indian health care trainees, dur-
ing six-month intervals, over four test points. Sec-
ondly, rates of TB exposure were estimated by type
of health care trainee, and evaluated whether QFT
conversions were associated with TB exposures,
and QFT reversions with treatment. HCWs were
categorized by patterns of QFT responses, to assess
whether different patterns were associated with
exposure. Secondary objectives were to assess
what occupational TB exposure factors (if any)
were associated with change in IFN-gamma re-
sponse over the four time points.2. Materials and methods
2.1. Study setting and population
This study was conducted at the Mahatma Gandhi
Institute of Medical Sciences (MGIMS), Sevagram,
a teaching hospital located in central India. The
hospital sees an average of 300 smear positive TB
cases per year, two thirds of which are treated as
in-patients. As MGIMS is a referral center, most
smear positive patients are seriously ill when they
reach the hospital and require hospitalization.
Approximately three quarters of all smear positive
in-patients are diagnosed only during in-patient
evaluation.
TB infection control measures are limited,
screening for LTBI is not routinely performed and
personal respirators are not routinely provided
(and when available not routinely employed by
HCWs when interacting with patients with active
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high prevalence of LTBI, high annual risk of TB
infection in young health care trainees, and a high
incidence of active TB among HCWs [7,15,18].
2.2. Study design and ethics approval
This longitudinal study was conducted from August
2007 to July 2009. Upon providing informed con-
sent, students completed a brief questionnaire on
occupational and non-occupational exposure to
TB prior to enrollment, and blood was drawn for
the QFT. Participants were followed up for
18 months and underwent blood draws and expo-
sure assessment every 6 months. TST was not done
as TST could have altered QFT responses [19]. Eth-
ical approval for the study was obtained from both
the McGill University Health Centre (MUHC) in Mon-
treal, Canada, and from the institutional review
board (IRB) of the MGIMS.
2.3. IGRA testing (QFT)
Participants were tested with the QuantiFERON-TB
Gold In-Tube (QFT) test (Cellestis, Inc./Qiagen,
Carnegie, Australia), performed as per the manu-
facturers instructions on site at the MGIMS labora-
tory. The QFT was considered positive if the
interferon-gamma (IFN-g) produced in the TB anti-
gen tube minus the IFN-g produced in the nil tube
was P0.35 IU/ml, as per the manufacturers
recommendations. Quantitative IFN-g values were
also recorded; results greater than 10 IU/ml or
less than 0 were truncated at 10 and 0 respectively;
as values outside this range are not precisely
measurable.
2.4. Questionnaire and ascertainment of TB
exposure
Exposure ascertainment was done by verifying de-
tailed log books kept by all trainees, outlining the
students daily responsibilities between each study
test point. Log books are used to monitor atten-
dance during the students hospital rotation duties,
and include what ward and patients (using a 12-di-
git hospital ID number) individual students were
responsible for each day. Typically, medical stu-
dents took part in 60-min rounds, while nursing stu-
dents had 15-min interactions per patient, but had
a higher number of patient interactions per day, in
which they help with vital signs, medications, and
bed care. Electronic discharge summaries of all pa-
tients who interacted with HCW trainees were ob-
tained to identify if they had TB, and it was
noted if it was pulmonary (sputum smear positiveor smear negative) or extra-pulmonary, and
whether the patient was on anti-tuberculosis treat-
ment (ATT) at the time of contact. In summary, the
measurement of exposure (i.e., quantity and dura-
tion of contact) for each individual student partic-
ipating in the study was based on actual time spent
caring for infectious TB patients. Occupational TB
exposures prior to study enrollment and non-occu-
pational TB exposures were collected through self-
administered questionnaires completed by the
HCW at each test point.
Using these detailed exposure durations col-
lected for each student, three cumulative exposure
variables were constructed: (a) total number of
days exposed to smear positive or smear negative
TB cases; (b) actual minutes exposed to smear po-
sitive TB cases only; and (c) number of days ex-
posed to an active TB patient, not on ATT.
2.5. Study definitions
Both conventional and alternative QFT conversion
definitions were assessed. Conversion definition
(A) uses the manufacturers recommended cut-off
point of a change from negative to positive (IFN-
gP 0.35 IU/ml). Conversion definition (B) was a
change from negative to positive (cut-off point
IFN-gP 0.35 IU/ml) and an absolute increase of
0.7 IU/ml over the first QFT result; this comes from
within-subject variability research conducted in
South Africa [19,20]. Conversion definition (C)
was the most stringent, with a change from nega-
tive to positive based on a threshold value of IFN-
gammaP 1.0 IU/ml, reflecting earlier research
conducted by this studys group [21]. QFT reversion
was defined as a change from a positive result to a
negative result (cut point <0.35 IU/ml). Conver-
sions and reversions were assessed with reference
to the QFT result from the previous testing period
(i.e., 6 months earlier).
Based on previous work, this research expected
to find five patterns of changes in dichotomous
QFT results over time [22]. The five patterns were:
(a) persistent negatives – all QFT negative results;
(b) persistent positives – all positive QFT results;
(c) stable conversions – QFT conversion at any
time point, and no subsequent reversion; (d) stable
reversions – QFT reversion at any time point, with
no subsequent conversion; and (e) unstable pat-
terns – at least one conversion and one reversion
over the study period [22].
2.6. Statistical analysis
All analyses were performed with Stata version 11
(Stata Corp, Texas, USA). The various definitions
Table 1 Characteristics of study participants (at enrollment unless otherwise stated).
Characteristic N = 270 (%)
Sex
Females 166 (61.5%)
Males 104 (38.5%)
Student type
Medical student 165 (61.1%)
Nursing student 105 (38.9%)
Age at first test (mean and IQR) 19.4 yers (18.4–20.5 yers)
Average monthly household income
<Rs. 5000 113 (41.85%)
Rs. 5000–10,000 78 (28.9%)
Rs. 10,001–20,000 25 (9.3%)
Rs. 20, 001–30,000 23 (8.5%)
>Rs. 30,000 30 (11.1%)
Did not want to report 1 (0.4%)
BCG Vaccination
Not vaccinated 41 (15.2%)
Vaccinated at birth 203 (75.2%)
Vaccinated after birth 1 (0.4%)
Do not know 25 (9.3%)
Year of entry into training program
2005 53 (19.6%)
2006 81 (30%)
2007 98 (36.3%)
2008 38 (14.1%)
Mean number of valid QFT results per participant 3.6 (min: 2, max: 4)
Diagnosed with TB in the past
No 266 (98.5%)
Yes 4 (1.5%)
Any medical postings prior to study enrollment
No 130 (48.15%)
Yes 140 (51.85%)
Any TB exposures in hospital prior to enrollment
No 177 (65.6%)
Yes 93 (34.4%)
Any TB exposures in the community prior to study enrollment
No 145 (53.7%)
Yes 23 (8.5%)
Did not report 102 (37.8%)
Completed 6 month LTBI treatment
No 252 (93.3%)
Yes 18 (6.7%)
Median number of days spent on medical wards per testing interval
Between QFT1 and QFT2 24 days (IQR: 0–111)
Between QFT2 and QFT3 25.5 days (13–40)
Between QFT3 and QFT4 12 days (5–21)
108 A. Zwerling et al.listed above were used to assess rates of QFT con-
versions and reversions. To evaluate the association
between the patterns of QFT results and cumulative
TB exposure, odds ratios and their accompanying
95% confidence intervals (CI) were estimated fromthe multivariable polytomous logistic regression
model, which allows for the simultaneous assess-
ment of multiple outcome categories [23].
Multiple longitudinal modeling techniques were
used to assess an association between recent
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comes: QFT positivity, conversions, or continuous
IFN-gamma. General estimating equations (GEE)
were used to estimate population-averaged mar-
ginal models for QFT positivity [24]. It was investi-
gated whether there was a difference in the effect
of the time dependent occupational exposure vari-
ables within-subject versus between subjects over
time [25]. Generalized linear mixed models
(GLMMs), estimated via adaptive quadrature, were
used to assess whether time-dependent occupa-
tional exposures were associated with QFT conver-
sions, using one of the three proposed conversion
definitions. Random intercepts and random slopes
were investigated for test point, initial inter-
feron-gamma values and key time dependent occu-
pational exposure variables. The final model
comparing QFT conversions (definition A) was a
random intercept only model, dummy variables
were used to account for high moderate and low
initial interferon gamma values, an interaction
term was investigated for test point and initial
IFN-gamma response at study enrollment. Finally,
a linear random effects model was fit to continuous
IFN-gamma values. Given that continuous IFN-gam-Figure 1 Days spent on medical wards for each interval b
medical wards for each student during each 6 month inter
participants with that number of exposed days per testing pma has both floor and ceiling effects, due to the
truncation of continuous IFN-gamma values at 0
and 10 IU/ml, there was concern about the
assumption of normality. Therefore, a mixed ef-
fects Tobit regression [26] was used to assess the
association between exposure and rates of change
in continuous IFN-gamma values while accounting
for the ceiling and floor effect seen in the distribu-
tion of continuous IFN-gamma.
3. Results
3.1. Participant demographics and exposure
to TB
A total of 270 trainees (165 [61.1%] medical and
105 [38.9%] nursing students) participated in the
study and completed testing. Table 1 summarizes
the characteristics of the study cohort. A total of
61.5% were female, median age was 19.4 years. Va-
lid QFT results were available for all 4 time points
in 196 participants, while 28 participants com-
pleted 3 tests, and 46 participants completed 2
tests (a total of 960 valid QFT results). Based on
the log books maintained by trainees, participantsetween testing. Histogram of number of days spent on
val between QFT testing. Frequency is the number of
eriod.
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spent on medical wards between each test point
respectively; a visual representation of time spent
on the wards for each interval is presented in Fig-
ure 1. Over the course of the study, 52 participants
(19.3%) were advised to take INH based on positive
test results at study enrollment. Among them, 18/
52 (34.6%) participants initiated INH therapy, and
all 18 completed 6 months of therapy. No partici-
pant was diagnosed with active TB during the study
period.
Upon initial testing, 64/226 (28.3%) HCWs re-
ported positive QFT test using the manufacturers
definition.
Table 2 describes the mean number of occupa-
tional exposures per testing period stratified by
type of trainee (i.e., medical or nursing). With
the exception of TB exposure in the community
prior to study enrollment, nursing students report
consistently a higher mean number of days exposed
during each testing period. While medical students
reported a mean of 15.5 (SD: 15.1) days working on
medical wards per 6 month period, nursing stu-
dents reported a mean of 80.9 (SD: 75.9) days.
The only exposure variable to be more common in
medical students was non-occupational TB expo-
sure prior to study enrollment, which was reported
in 24/420 (5.7%) nursing students and 68/660
(10.3%) medical students. QFT positivity at study
enrollment was similar between groups; 27.5%Table 2 Occupational exposures and QFT results stratified by
Occupational exposures Medical stud
Mean numbe
(in days or m
between QF
Days exposed to smear positive TB patients 0.94 (SD*: 1.
Days spent working on medical wards 15.5 (SD: 15
Days exposed to TB patients NOT on anti-
TB therapy (ATT)
0.23 (SD: 0.8
Time (in minutes) exposed to smear
positive patients
56.7 (SD: 10
Any TB exposures in hospital prior to
enrollment n/N (%)
192/660 (29
Any TB exposures in the community prior
to study enrollment n/N (%)
68/660 (10.3
QFT outcome QFT positivi
Initial QFT positivity 44/160 (27.5
QFT conversion rate (at any time point) 54/307 (17.6
QFT reversion rate (at any time point) 35/119 (29.4
* SD: standard deviation
** For this analysis each period (i.e., QFT1 to QFT2 or QFT2 to QFT3
denominators represent the number of eligible participants at ea
conversion, participants must have had a negative QFT on the previ
QFT at the start of the interval. To be eligible for a reversion, partic(44/160) QFT positive medical students and 20/66
(30.3%) QFT positive nursing students.
3.2. Conversion and reversion rates
When QFT conversion rates were estimated among
medical and nursing students, treating each period
as an independent observation, the QFT conversion
rate (54/307) among medical students was 17.6%,
and the QFT conversion rate (9/134) among nursing
students was 6.7%, despite higher levels of re-
ported exposures in nursing students. Employing a
more stringent cut-off point consistently resulted
in decreased conversion rates across all test points,
but little difference was found between the more
strict conversion definitions (B and C).
Table 3 presents the total number of conver-
sions, at any test point, stratified by participant
characteristics and TB exposure at enrollment.
Conversions were less frequent among participants
with occupational and non-occupational TB expo-
sures prior to study enrollment. For occupational
exposures collected post-study enrollment, the
mean number of days or minutes exposed per
6 month period between testing dates was calcu-
lated (Table 4). The Mann–Whitney test was used
to assess whether the median number of exposures
was different between participants with conver-
sions and participants with stable negatives. For
mean number of days spent working on medicaltype of medical trainee.
ents Nursing students
r of exposures
inutes) per 6 months
T tests
74) Range: 0–9 12.4 (SD: 17.7) Range: 0–126
.1) Range:0–180 80.9 (SD: 75.8) Range:0–180
8) Range:0–7 4.5 (SD: 6.58) Range:0–54
4.47) Range:0–540 185.6 (SD: 265.4) Range: 0–1890
.1%) 180/420 (42.9%)
%) 24/420 (5.7%)
ty and conversions – n/N (%)**
%) 20/66 (30.3%)
%) 9/134 (6.7%)
%) 9/65 (13.9%)
) was treated as a separate and independent event. Therefore,
ch time point to convert or revert. In order to be eligible for
ous test; therefore denominators are the number with negative
ipants must have had a positive QFT result on the previous test.
Table 5 Conversion and reversion rates at each follow-up, using different conversion definitions.
Conversion definition* 6 month 12 month 18 month
A 18/159 (11.3%) 16/143 (11.2%) 29/139 (20.9%)
B 11/159 (6.9%) 11/143 (7.7%) 20/139 (14.4%)
C 10/159 (6.3%) 10/143 (7%) 16/139 (11.5%)
Reversion** 16/61 (26.2%) 16/63 (25.4%) 12/60 (20%)
* Conversion definitions: (A) change from negative to positiveP0.35 IU/ml, (B) change from negative to positiveP0.35 IU/ml and
0.7 IU/ml absolute increase, (C) change from negative to positive P1.0 IU/ml.
** Reversion defnition: change form positive (P0.35 IU/ml) to negative (<0.35 IU/ml).
Table 3 QFT conversion rates at any test point (using manufacturers conversion definition) in Indian trainees stratified by
participant characteristics.
Characteristic Conversions (n/N)*
Sex
Females 28/250 (11.2%)
Males 35/191 (18.3%)
Student type
Medical student 54/307 (17.6%)
Nursing student 9/134 (6.7%)
Completed 6 month LTBI treatment
No 60/437 (13.7%)
Yes 3/4 (75%)
Any TB exposures in the community prior to study enrollment
No 60/410 (14.6%)
Yes 3/31 (9.7%)
Any medical postings prior to study enrollment
No 39/215 (18.1%)
Yes 24/226 (10.6%)
Any TB exposures in hospital prior to enrollment
No 48/296 (16.2%)
Yes 15/145 (10.3%)
* For this analysis, each period (i.e., QFT1 to QFT2 or QFT2 to QFT3) was treated as a separate and independent event. Therefore,
denominators represent number of eligible participants at each time point to convert. In order to be eligible for conversion,
participants must have had a negative QFT on the previous test, therefore denominators are the number with negative QFT at the
start of the interval.
Table 4 Mean number of occupational exposures reported per 6 month period between testing among participants with
conversions versus persistent negatives.*
Occupational exposures reported per
6 month period between testing
Converters (n = 63) Stable negatives (453) p Value: Mann Whitney
test of medians
Mean number of days exposed to smear
positive TB patients
2.8 (SD: 9.9) 5.7 (SD: 12.9) p = 0.57
Mean number of days spent working on
medical wards
17.1 (SD: 31.8) 52.3 (SD: 67.0) p = 0.00
Mean number of days exposed to TB
patients NOT on anti-TB therapy (ATT)
0.71 (SD: 3.0) 2.1 (SD: 5.1) p = 0.22
Mean time in minutes exposed to smear
positive patients
100.5 (SD: 193.4) 109.3 (SD: 200.5) p = 0.66
* This analysis treats each period from QFT1 to QFT2, QFT2 to QFT3, etc., as one independent observation.
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112 A. Zwerling et al.wards, it was found that converters had a statisti-
cally smaller mean number than did stable nega-
tives (17.1 vs. 28, p = 0.01). Similarly, converters
reported a smaller number of mean days in contact
with TB patients not on anti-TB therapy (0.71 vs.
1.6, p < 0.01).
Conversion and reversion rates for each test per-
iod are presented in Table 5. Using the manufac-
turers conversion definition, 18/159 (11.3%)
conversions were identified at QFT 2 among partic-
ipants with negative QFT 1. At QFT 3, 16/143
(11.2%) conversions were identified among QFT 2
negative participants, and 29/139 (20.9%) conver-
sions at QFT 4 were found among participants with
negative QFT 3 results. Reversion rates were fre-
quently higher than conversion rates, 16/61
(26.2%) at QFT 2 among those with positive QFT 1 re-
sults, 16/63 (25.4%) at QFT 3 among participants
with positive QFT 2 results and 12/60 (20%) rever-
sions at QFT 4 among participants with positive
QFT 3. Denominators for reversion rates are smaller
at each test point compared with conversion rates
as fewer participants were QFT positive and thus eli-
gible for a reversion upon subsequent testing.
3.3. Conversions and/or reversions stratified
by initial IFN-gamma values
Conversion and reversion rates using the manufac-
turers cut-off point and stratified by initial quanti-
tative QFT results are presented in Table 6. The
majority of these trainees were young and had lim-
ited exposure to TB prior to enrollment in the pro-
gram, therefore IFN-gamma response at study
enrollment might be a useful predictor of QFT pat-
terns over time. Conversion and reversion rates
were calculated at each test point, the denomina-
tors for conversion/reversions rates were all HCWs
with a negative/positive QFT at the previous testTable 6 Conversion and reversion rates at 6, 12 and 18 mo
enrollment (using conversion definition A: P0.35 IU/ml).
QFT at study
enrollment:
TB Ag- Nil (IU/ml)
Participants
with result, n (%)
Conversions
at QFT 2
<0.01 68 (31%) 10/68 (15%)
0.01–0.19 75 (34%) 5/75 (7%)
0.2–0.34 16 (7%) 3/16 (19%)
Reversions at QFT 2
0.35–0.49 5 (2%) 2/5 (40%)
0.5–0.69 4 (2%) 4/4 (100%)
0.7–0.99 6 (3%) 3/6 (50%)
1–2.99 12 (5%) 5/12 (42%)
3.00+ 34 (15%) 2/34 (6%)point. Therefore, a HCW with an initial QFT 1 posi-
tive could have a reversion at QFT 2 and a subse-
quent conversion at QFT 3. Higher conversion
rates at QFT 3 and QFT 4 can be seen among those
participants with higher QFT 1 IFN-gamma results
(i.e., 33–80% conversion at QFT 3 among QFT 1 pos-
itives vs. 9–19% QFT 3 conversion rates among those
with QFT 1 negative results). Similar patterns can be
seen among QFT reverters, where among QFT 1 neg-
atives, reversion rates were high and ranged from
67% to 80%, while among the QFT 1 positives, rever-
sion rates were between 0% and 33%. This was inves-
tigated further in the longitudinal analysis.
3.4. Patterns of change over 18 months
Each participant was classified into one of five
groups based on their cumulative 18 month QFT pat-
tern. Using the manufacturers definition of a posi-
tive test, 151/270 participants (55.9%) were
persistently negative, 45/270 (16.7%) were persis-
tently positive, 29/270 (10.7%) participants had a
stable conversion, 11/270 (4.1%) had a stable rever-
sion, and finally 34/270 (12.6%) of participants had
unstable patterns. Figure 2A–E are trajectory plots
of the quantitative IFN-g values over time within
each participant stratified by QFT patterns. These
demonstrate the wide variability of responses over
time within some participants, and the diversity
across subgroups. The variability among persis-
tently positive and unstable patterns appears to
be much larger compared with the variability seen
among the persistently negatives. These patterns
should be interpreted as a slice in time; looking at
Figure 2 it can be observed that many of the stable
converters converted at QFT 3 or QFT 4.
Multivariable polytomous logistic regression was
performed to assess whether known TB risk factors
and cumulative 18 month occupational exposurenths stratified by quantitative IFN-gamma values at study
Conversions
at QFT 3
Conversions
at QFT 4
Reversions
at QFT3
Reversions
at QFT 4
5/58 (9%) 11/61 (18%) 8/10 (80%) 4/7 (57%)
13/70 (19%) 14/61 (23%) 4/5 (80%) 8/14(57%)
2/13 (15%) 3/13 (23%) 2/3 (67%) 2/3 (67%)
1/2 (50%) 1/2 (50%) 1/3 (33%) 1/3 (33%)
3/4 (75%) 1/1 (100%) – 1/3 (33%)
1/3 (33%) 1/2 (50%) 0/3 (0%) 2/4 (50%)
4/5 (80%) 1/1 (100%) 0/7 (0%) 4/11 (36%)
1/2 (50%) 1/2 (50%) 1/32 (3%) 1/32 (3%)
Figure 2 Trajectory plot of interferon-gamma (TB antigen – nil) over 4 test points, by participant. Trajectory plots
of continuous interferon-gamma (TB antigen – nil, IU/ml), within each participant over time. Plots are presented for
all students with the same 18 month QFT trajectory together (i.e., A: all students with persistent negative patterns; B:
all students with persistent positive patterns, etc.).
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Stable converters were more likely to have had
exposure to TB in the hospital prior to baseline
testing (OR = 14.3, 95% CI: 2.1–96.8), while unsta-
ble patterns were significantly less likely to have
had exposure to TB in the hospital prior to study
enrollment (OR = 0.2, 95% CI: 0.0–0.8).3.5. Longitudinal analysis: QFT positivity
and conversions
Next, it was assessed whether (a) QFT positivity or
(b) QFT conversions (both binary outcomes) were
associatedwith occupational exposures to TB occur-
ring between each QFT test point. Occupational
114 A. Zwerling et al.exposure variables were collected in a time-depen-
dent manner (i.e., for each interval between test-
ing) and included: days/time working on medical
wards, days/time exposed to smear positive pa-
tients, total days/time exposed to smear positive
and smear negative and extra-pulmonary patients,
and finally total days exposed to active TB patients
not on ATT. Non-linear shapes for the exposure out-
come association were investigated, but the best fit
was a linear characterization of exposure.
3.5.1. Is QFT positivity associated with
occupational TB exposure over time?
To account for correlation among QFT results from
the same participant, a GEE approach was used to
estimate a population-averaged model. The within-
subject effect of increasing number of days spent
working on medical wards was significantly associ-
ated with increasing rates of QFT positivity in the
marginal model. The effect appeared small
(OR = 1.01 per day on medical ward, 95% CI:
1.00–1.02), but an accumulation of days between
testing could lead to a clinically meaningful effect.
While there was a significant effect of exposure
within-subjects, when comparing between HCWs,
the effect of exposure was no longer statistically
significant, suggesting other factors may influence
QFT positivity across HCWs.3.5.2. Are conversions associated with
occupational exposure over time?
Next, it was assessed whether QFT conversions (not
simple positivity) were associated with occupa-
tional exposure over time in this population. Three
conversion definitions were assessed in this analysis
(A through C). A minimum of two valid QFT results
were required to establish a conversion, and as
such, the total number of observations decreased
for this analysis to 404, with an average number of
observations of 2.8 per participants (range: 1–3).
It was assessed whether conversions (using defi-
nitions A–C) were associated with occupational
exposure using a random effects model estimated
using quadrature. Between- and within-subject ef-
fects were not statistically significantly different in
this analysis with conversions. None of the occupa-
tional exposure variables investigated were associ-
ated with QFT conversions using any of the three
proposed conversion definitions.Figure 3 Histogram of continuous interferon-gamma
results from all time points. Continuous interferon-
gamma (TB antigen minus the nil) measured using the
QFT-GIT test, from all participating students and across
all time points, n = 960.3.6. Longitudinal analysis: change in
continuous interferon-gamma
To evaluate whether exposure over time was asso-
ciated with rates of change in continuous IFN-gam-ma values, a random effects Tobit model was used
to account for the ceiling and floor effect seen
among continuous IFN-g values, which are trun-
cated at 0 and 10 (Figure 3). In univariable analysis
using the Tobit model, it was found that days hav-
ing worked on medical wards (within-subject ef-
fect) were statistically significantly associated
with a positive change in quantitative IFN-gamma,
but this was no longer statistically significant in the
final multivariable Tobit model. High initial IFN-
gamma values (>1.0 IU/ml) were associated with
a 6.09 unit increase in IFN-g over time in the ad-
justed model (95% CI: 5.08–7.10).
4. Discussion
Results from this serial testing study in India show
high conversion and reversion rates using QFT
among this young cohort of medical and nursing
students, and is consistent with our previous stud-
ies in India and recent publications from low TB
incidence settings demonstrating high rates of con-
versions and reversions upon serial testing HCWs
[15,27]. While employing more stringent conver-
sion definitions did reduce apparent rates of con-
versions and reversions at QFT 2, QFT 3 and QFT
4, alternative conversion definitions were not any
more strongly associated with known TB exposure
or recent occupational TB exposure. Using four dif-
ferent methods of longitudinal analysis, recent TB
exposure was found to be statistically significantly
associated with QFT positivity in only one model,
and then only to a limited degree. QFT reversion
rates were high across all time points (20–26.2%),
and reversions pose a concern for clinicians trying
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sitive HCW. Indeed, other recent publications have
demonstrated reversions irrespective of treatment
[28,29]. It remains unclear whether reversions rep-
resent a clearing of infection or whether the initial
positive QFT could be a transient immunological
response as opposed to true TB infection.
The only variable to be significantly associated
with any cumulative 18 month QFT pattern was
exposure to TB in the hospital prior to study enroll-
ment. Interestingly, while it was positively associ-
ated with stable converters, exposure in the
hospital was less likely to be reported among those
with unstable QFT patterns. This may suggest that
exposure to TB in the hospital was a good predictor
of a stable pattern. Alternatively, this could sug-
gest that students without any prior hospital expo-
sure are more likely to experience unstable
patterns initially, until their IFN-gamma levels
stabilize.
In a population averaged model with QFT posi-
tivity as the outcome, it was observed that days
spent working on medical wards were associated
with increased odds of being QFT positive within
a HCW. However, when comparing across HCWs,
this effect was no longer significant, suggesting
other factors affect QFT positivity between HCWs.
It is possible that individual subjects infection con-
trol practices and knowledge, which were not cap-
tured in this analysis, could explain why increased
exposure was associated with increased positivity
within-subjects but not across subjects. Alterna-
tively, there may be some unknown underlying
immunological phenomenon at play. This effect
was significant in only one of the four longitudinal
analyses investigated, and was significantly differ-
ent between and within participants. Recent occu-
pational exposure was not associated with QFT
conversions or continuous IFN-gamma results.
In the QFT conversion analysis, no association
was found between QFT conversions and occupa-
tional exposures using any of the three proposed
conversion definitions. The only time dependent
occupational TB exposure variable to be statisti-
cally significantly associated with any outcome
investigated was days spent working on medical
wards, and while exposure to known smear positive
cases may correlate better with intensity of expo-
sure, days spent on medical wards will capture
cumulative known plus unknown occupational TB
exposure; the latter may be considerable in this
high TB incidence environment.
One potential explanation for the high rate of
conversions and reversions may be the lack of
reproducibility of the assay itself. T cell assays
such as the IGRAs may be influenced by variabilityin manufacturing, pre-analytical and analytical
procedures as well as immunological differences
in samples taken from the same person at different
times [30]. A systematic review published in 2009
demonstrated that within-subject IGRA reproduc-
ibility ranged from 16% to 80% in continuous IFN-
gamma response and could result in changes in
dichotomous positive/negative results [19]. Re-
cently, Doberne et al. demonstrated that delays
in incubation time between two samples taken
from the same person at the same time could result
in discordant test results [31] and other studies
have reported similar issues [32–34]. These issues
deserve further exploration, particularly in settings
with high levels of TB exposure.
4.1. Strengths and limitations
A major strength of this study was its being con-
ducted in a high TB incidence setting. There are
few serial testing studies from high TB incidence
settings, and fewer still that have examined any
sort of occupational exposure. Another key
strength of this work was the direct ascertainment
of detailed exposure to infectious TB patients. The
study design took advantage of detailed records of
occupational and community TB exposure within
the medical school training program to directly
capture actual time spent caring for active TB pa-
tients. In addition, by using discharge summaries,
the smear status of active TB cases and whether
patients were on anti-tuberculosis treatment at
the time of contact were identified, thus establish-
ing whether patients were contagious at the time
of contact. Furthermore, all medical and nursing
trainees at this school are required to live in on-
campus dormitory-style housing, so that commu-
nity exposure during their training program is rela-
tively low.
However, India is a high TB incidence setting,
and the possibility of unknown or un-documented
exposure to TB cannot be ruled out. While a major
attempt was made to obtain detailed exposure
assessment, the possibility that the log books
which are used for attendance and monitoring are
not entirely accurate cannot be eliminated, any
extracurricular activities or additional time train-
ees spent in the wards would not have been re-
corded as part of the training logs.
Finally, modeling techniques particularly suited
to longitudinal data were used to account for the
within-subject serial correlation of QFT results over
time. However, these although a large number of
test points were available, the small number of out-
come events, together with a large number of po-
tential predictors, means that confidence intervals
116 A. Zwerling et al.are wide, and inference should be made with
caution.
5. Conclusion
Overall, these findings confirm the previous litera-
ture on the highly dynamic nature of IFN-gamma
responses over time, and suggest IGRAs may not
be an ideal diagnostic test for repeated screening
of HCWs [35]. IFN-gamma trajectories as measured
by QFT are highly correlated within-subjects over
time, and observed changes could not be explained
by occupational exposure variables investigated in
a longitudinal analysis. Indeed, in four multivari-
able models assessed, only two demonstrated any
association between occupational TB exposure
and QFT results, while the type of exposure associ-
ated with QFT results was not consistent across dif-
ferent analyses. Increasing number of days spent
on medical wards was associated with an increased
risk of QFT positivity within-subjects, but the ef-
fect was not seen between subjects, suggesting
the effect of exposure is somehow washed out by
other unmeasured differences between subjects,
such as underlying immunological phenomena or
personal infection control practices. High conver-
sion and subsequent reversion rates suggest that
not all HCWs with positive QFT results have true la-
tent TB infection requiring IPT; alternatively, there
may be persistent infection, yet variable QFT re-
sponses fail to reflect this. Many would revert in
the absence of treatment; either because they
were not truly infected, or by clearing the infec-
tion naturally. Treating all HCWs with positive
QFT could result in unnecessary adverse events
and increased costs. Finally, the lack of clear and
strong associations between investigated occupa-
tional exposure and QFT conversions, or continuous
IFN-gamma changes suggest that QFT alone may
not be the ideal strategy for identifying LTBI in rou-
tine screening of HCWs in high TB incidence
settings.
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